FGN Futuragene

 

TIDMFGN 
 
RNS Number : 6131S 
Futuragene PLC 
21 May 2009 
 

FUTURAGENE PLC ("FuturaGene" or the "Company") 
 
 
FuturaGene's Wholly Owned Subsidiary, CBD Technologies, Ltd. ("CBD Tech") and 
Targeted Growth, Inc. ("TGI") to begin Field Trials in Corn and Amend Licensing 
Agreement 
 
 
Rehovot, Israel 
21 May 2008 
 
 
FuturaGene, which develops environmentally friendly solutions that enhance crop 
yields and improve the processability of plants for biofuels, biopower, forestry 
and agriculture announces that Targeted Growth, Inc. is to initiate the first 
field trials with corn, modified with technology from CBD Tech. The technology 
is aimed at enhancing plant processability and digestibility as well as other 
agronomic properties. The trials are aimed at screening for altered lines to 
take forward in the development pathway. 
 
 
CBD Tech has also amended its licensing agreement of 19 March 2008 (the 
"Agreement") with TGI for the enhancement of corn and soybean. As TGI is to 
focus its efforts on the enhancement of corn with the technology from CBD Tech, 
it has decided not to initiate work on soybean and the amended Agreement will no 
longer include this crop.  As detailed above, TGI continues to progress with 
corn and all terms, definitions, provisions and conditions of the Agreement 
remain in full force and effect with respect to this latter crop. 
 
 
For further information, please contact: 
 
 
 
 
FuturaGene Plc 
Mark Pritchard, Chairman 
                                       +44 (0) 7802 827 846 
Dr. Stanley Hirsch, Group CEO 
                                         +972 544 56 2724 
 
 
Evolution Securities 
Neil Elliot 
                                                   +44 (0) 20 7071 4300 
 
 
Targeted Growth, Inc. 
John Williams, Scoville PR 
                                                 +1(206)6250075 
 
 
 
 
About FuturaGene PLC 
 
 
FGN is a leading agricultural biotechnology company focused on research, 
development, 
and commercialisation of technologies that play key roles in substantially 
improving 
agronomic traits of value in plants. In particular the Company is focused on the 
development and commercialisation of genetically modified plants for improving 
and 
protecting yields, and enhancing processability and environmental sustainability 
in the 
forestry, biofuels, biopower and agricultural sectors. In addition to its 
in-house discovery program, FuturaGene licenses intellectual property from 
leading universities in its strategic fields of interest and is exploiting the 
synergies of these technologies with the cell wall modification platform of its 
wholly owned subsidiary, CBD Technologies, Inc. (CBD Tech) in forestry, biofuel, 
biopower, food and feed crops. 
 
 
CBD Tech has pioneered a modality for modifying plant cell walls, resulting in 
enhanced growth and biomass, increased cellulose, improved fiber properties, 
improved digestibility and processability, and increased yield properties and 
has secured broad intellectual property covering plants with modified cell walls 
showing such altered properties. More information is available at 
www.futuragene.com. 
 
 
 
 
About Targeted Growth Inc. 
TGI uses agricultural bioscience to enable the long term success of renewable 
fuels such as biodiesel and ethanol. This includes technology that improves the 
traits of crops themselves (yield increases, drought resistance, fertilizer 
requirements, etc.) and the ultimate performance of those crops once converted 
into biofuels (efficiency of refining, fuel performance characteristics). In 
addition, the company also develops, grows and markets biofuel specific crops 
(such as camelina) that are optimised and continually improved for use 
specifically as a feedstock for biofuels. The company has strategic partnerships 
with leading researchers and agribusinesses around the world. Targeted Growth is 
based in Seattle, Washington with labs in Seattle, Saskatchewan, Ottawa and New 
Brunswick. More information is available at www.targetedgrowth.com. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCILFEDEAIIFIA 
 

Futuragene (LSE:FGN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Futuragene (LSE:FGN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024